ArticleEuropean journal of nuclear medicine and molecular imaging2026

Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study.

Felix Schmidt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.